FIELD: medicine.
SUBSTANCE: invention refers to medicine. A method involves application of IL-31 antagonist for IL-31 induced signal transduction inhibition in dorsal root ganglion cells. The IL-31 antagonist inhibits IL-31 polypeptide binding containing amino acid residues 27-164 SEQ ID NO:2 with its heterodimeric receptor containing IL-31RA and OSMR-beta. The antagonist represents a humanized monoclonal antibody or a chimeric antibody.
EFFECT: use of the method effectively relieves inflammation, pain and itching.
8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING INFLAMMATION IN NEURONAL TISSUE WITH USING MONOCLONAL ANTIBODY AND ITS BINDING FRAGMENT | 2007 |
|
RU2565391C2 |
IL-31 MONOCLONAL ANTIBODIES AND METHODS OF USING | 2006 |
|
RU2444528C2 |
THERAPEUTIC AGENT FOR ITCHING | 2008 |
|
RU2541780C2 |
THERAPEUTIC AGENT FOR ITCHING | 2008 |
|
RU2596397C2 |
NEW LIGAND OF CYTOKINE RECEPTOR ZCYTOR17 | 2003 |
|
RU2490276C2 |
PREVENTIVE AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASE | 2007 |
|
RU2511406C2 |
HISTAMINE PRODUCING BACTERIAL STRAINS AND THEIR APPLICATION FOR MALIGNANT TUMORS | 2016 |
|
RU2747390C2 |
MONOCLONAL ANTIBODIES AGAINST IL-21 OF HUMAN BEING | 2008 |
|
RU2504552C2 |
COMPOSITIONS AND METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATING CYTOKINE SIGNAL TRANSMISSION | 2006 |
|
RU2426742C2 |
PRODUCTION AND APPLICATION OF BACTERIAL HISTAMINE | 2012 |
|
RU2628536C2 |
Authors
Dates
2012-01-20—Published
2007-01-10—Filed